关于FGFR基因改变固体瘤的诊断和治疗的专家共识
Chunwei Xu1,2, Bin Lian3, Juanjuan Ou4
1Department of Scientific Research, Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou Zhejiang 310022, People's Republic of China.
Global medical genetics
|November 25, 2024
概括
纤维细胞生长因子受体 (FGFR) 突变驱动癌症,但FGFR抑制剂提供临床益处. 标准化FGFR变异的诊断和治疗方法对于有效的向治疗至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 纤维细胞生长因子受体 (FGFR) 是一个受体氨酸激酶,对正常细胞功能至关重要.
- 异常的FGFR信号,通过突变,融合或放大,有助于各种癌症.
- 像FGFR抑制剂这样的向疗法在特定的癌症类型中已经证明了临床疗效.
研究的目的:
- 建立专家共识,以标准化FGFR基因突变的诊断和治疗.
- 促进FGFR抑制剂在癌症患者的临床应用.
- 为FGFR变异的适当检测方法的选择提供指导.
主要方法:
- 关于FGFR突变和向治疗的当前文献的综述.
- 专家小组讨论,就诊和治疗策略达成共识.
- 评估各种检测方法,包括PCR,NGS,FISH和IHC.
主要成果:
- 通过破坏表观遗传和转录调节,FGFR的改变与癌症的发展有关.
- 已批准的FGFR抑制剂 (erdafitinib,pemigatinib) 在特定的FGFR突变癌症中显示出有效性.
- 针对FGFR变异进行有效的查对于患者选择至关重要.
结论:
- 需要对FGFR突变进行标准化的诊断和治疗方案.
- 专家的共识旨在优化FGFR抑制剂在临床实践中的使用.
- 适当选择检测方法是指导治疗决策的关键.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
09:49Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
9.5K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K